131 related articles for article (PubMed ID: 11301391)
21. Understanding medulloblastoma.
Quinlan A; Rizzolo D
JAAPA; 2017 Oct; 30(10):30-36. PubMed ID: 28953021
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.
Fouladi M; Gajjar A; Boyett JM; Walter AW; Thompson SJ; Merchant TE; Jenkins JJ; Langston JW; Liu A; Kun LE; Heideman RL
J Clin Oncol; 1999 Oct; 17(10):3234-7. PubMed ID: 10506624
[TBL] [Abstract][Full Text] [Related]
23. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
24. [Clinical course and prognosis in medulloblastoma in infants and young children].
Wagner W; Böttcher HD; Korinthenberg R; Schadel A; Schmilowski M
Klin Padiatr; 1983 Mar; 195(2):100-2. PubMed ID: 6855144
[TBL] [Abstract][Full Text] [Related]
25. Medulloblastoma presenting as dialysis disequilibrium syndrome.
Dilena R; Paglialonga F; Barbieri S; Edefonti A
Hemodial Int; 2011 Oct; 15 Suppl 1():S64-7. PubMed ID: 22093604
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
27. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
28. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
29. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
30. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
[TBL] [Abstract][Full Text] [Related]
31. [Medulloblastoma in adults].
Hopf-Jensen S; Buchalla R; Preiß M; Feist H; Börm W; Müller-Hülsbeck S
Rofo; 2014 Sep; 186(9):825-8. PubMed ID: 25171381
[No Abstract] [Full Text] [Related]
32. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
33. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome.
Brasme JF; Grill J; Doz F; Lacour B; Valteau-Couanet D; Gaillard S; Delalande O; Aghakhani N; Puget S; Chalumeau M
PLoS One; 2012; 7(4):e33415. PubMed ID: 22485143
[TBL] [Abstract][Full Text] [Related]
34. Medulloblastoma in adults.
Sheikh BY; Kanaan IN
J Neurosurg Sci; 1994 Dec; 38(4):229-34. PubMed ID: 7562028
[TBL] [Abstract][Full Text] [Related]
35. Does age affect presenting symptoms in children with carbon monoxide poisoning?
Kurt F; Bektaş Ö; Kalkan G; Öncel MY; Yakut HI; Kocabaş CN
Pediatr Emerg Care; 2013 Aug; 29(8):916-21. PubMed ID: 23903672
[TBL] [Abstract][Full Text] [Related]
36. Presentation and symptom interval in children with central nervous system tumors. A single-center experience.
Stocco C; Pilotto C; Passone E; Nocerino A; Tosolini R; Pusiol A; Cogo P
Childs Nerv Syst; 2017 Dec; 33(12):2109-2116. PubMed ID: 28808765
[TBL] [Abstract][Full Text] [Related]
37. Review of the prognostic factors in medulloblastoma of children and adults.
Brandes AA; Paris MK
Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
[TBL] [Abstract][Full Text] [Related]
38. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.
Caputy AJ; McCullough DC; Manz HJ; Patterson K; Hammock MK
J Neurosurg; 1987 Jan; 66(1):80-7. PubMed ID: 3783262
[TBL] [Abstract][Full Text] [Related]
39. [Histological diagnosis of brain tumors: (19). Medulloblastoma].
Nagashima K
No Shinkei Geka; 1992 Jan; 20(1):9-13. PubMed ID: 1738431
[No Abstract] [Full Text] [Related]
40. Supratentorial leptomeningeal metastasis of a medulloblastoma without cerebellar tumor recurrence.
Gerlach R; Kieslich M; van de Nes J; Galow W; Seifert V
Acta Neurochir (Wien); 2002 Feb; 144(2):201-4; discussion 204. PubMed ID: 11862522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
